Clinical Trials Logo

Filter by:
NCT ID: NCT01114412 Completed - Healthy Clinical Trials

Basic Sensations Coming From the Bladder

Start date: September 2009
Phase:
Study type: Observational

A major complication in studies to identify the nature of bladder sensations is language. It is difficult, if not near impossible, for the lay person, with no knowledge of physiology, anatomy or pathology, to put into simple terms a description of basic visceral sensations. Therefore, before the investigators can speculate about the detailed mechanisms generating sensation the investigators must overcome this language and communication difficulty. This will be addressed in the present study. There are important reasons why the investigators must identify the mechanisms generating the different sensations as the bladder fills. One of them is that these are basic physiological mechanisms which need to be better understood.

NCT ID: NCT01114100 Completed - Depression Clinical Trials

The Effects of Treatment With Sertraline for Noncardiac Chest Pain

Start date: January 2000
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether care as usual or intervention (consisting of sertraline versus placebo), are effective in the treatment of panic disorder and/or depression driven noncardiac chest pain.

NCT ID: NCT01113814 Completed - Chronic Hepatitis C Clinical Trials

Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV

Start date: n/a
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of Acoustic Radiation Force Impulse (ARFI)- Imaging compared to Transient Elastography (FibroScan) in differentiating liver fibrosis in patients with chronic hepatitis C. Patients who are scheduled to have a liver biopsy will also undergo ARFI and FibroScan testing. The liver biopsy will be used as the reference method. The target sample size is 433.

NCT ID: NCT01112865 Completed - Clinical trials for Growth Hormone Deficiency

Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

CHOOSE
Start date: August 2010
Phase: Phase 3
Study type: Interventional

Convenience and preference for the new Mark VII pen compared to the current Genotropin pen will be assessed using a questionaire. it is expected that the new pen will be preferred or at least no different to the current pen.

NCT ID: NCT01112579 Completed - Heart Failure Clinical Trials

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure

DEFEAT-HF
Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the feasibility of spinal cord stimulation (SCS) as a chronic therapy for systolic heart failure.

NCT ID: NCT01112306 Completed - Clinical trials for Pulmonary Arterial Hypertension

ACT-293987 in Pulmonary Arterial Hypertension

Start date: July 7, 2010
Phase: Phase 3
Study type: Interventional

Long-term, single-arm, multicenter, open-label extension, Phase 3 study, to evaluate the safety and tolerability of ACT-293987 in patients with PAH who participated in the double-blind study AC-065A302 (GRIPHON)

NCT ID: NCT01112137 Completed - Blood Pressure Clinical Trials

Effects of Clopidogrel on Blood Pressure

Start date: January 2005
Phase: Phase 4
Study type: Interventional

Context: Soluble CD40 ligand (sCD40L) released from activated platelets induces inflammatory transformation of the vascular endothelium and is an independent predictor of cardiovascular events. Arterial hypertension is associated with platelet activation, increased sCD40L levels and endothelial dysfunction suggesting that inhibition of platelet-derived sCD40L release may improve endothelial function and lower blood pressure (BP). Objective: To determine the effects of clopidogrel on sCD40L, endothelial function and BP. Design: Randomized, controlled, investigator-blinded, parallel-group, 2-phase trial in patients with coronary artery disease and essential arterial hypertension and those without hypertension. Intervention: Participants receive a single 600-mg clopidogrel loading dose (phase I) followed by a daily 75-mg clopidogrel maintenance dose over 28 days (phase II). Outcome Measures: Primary outcome measure is the change in BP from baseline. Secondary outcome measures are changes in biomarkers of platelet and endothelial function and their correlation with BP.

NCT ID: NCT01110980 Completed - Clinical trials for Neoplasms, Head and Neck

Normalcy of Food Intake in Head and Neck Cancer Patients

FOCISD
Start date: March 2010
Phase: N/A
Study type: Interventional

- Background: Oral nutrition appears to be a challenge for patients with head and neck cancer after radiotherapy. Many patients desire to (their) `normal food intake` and return to oral nutrition with normal consistency without modifications and diet formulas. Due to the dysphagia experienced post treatment this seems tremendously difficult. Referral to a speech-language therapist for swallowing therapy is no standard procedure. - Study design: A prospective randomized study in patients with a tumor in Oral cavity, Nasopharynx, Oropharynx, Hypopharynx or Larynx with stage II-IV (UICC TNM-tumor classification), ≥ 18 years, eligible for primary treatment with (chemo)radiation or adjuvant radiotherapy with curative intent. - Intervention: Individually tailored swallowing therapy by an experienced speech-language therapist in cooperation with individual dietary counselling (by an experienced dietician, `usual care`) pre-, per- and post treatment (until 6 months after treatment). This might improve `normalcy of food intake`, quality (no food modifications) and quantity of food intake and besides decrease the use of tube feeding and/or nutritional supplements. Also patients quality of life and nutritional status may be influenced positively. - Study hypothesis: The purpose of this study is to determine whether combined individual swallowing therapy and individual dietary counselling in patients with head and neck cancer receiving (chemo)radiotherapy can improve 'normal food intake'. Food intake without modifications and tube feeding and/or nutritional supplements.

NCT ID: NCT01110915 Completed - Clinical trials for Magnetic Resonance Imaging

Advisa MRI Clinical Study

Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of the Advisa MRI System clinical study is to confirm safety and effectiveness in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans up to 2W/kg Specific Absorption Rate (SAR) without positioning restrictions (MRI scans may occur anywhere on the body including the chest).

NCT ID: NCT01110369 Completed - Sarcopenia Clinical Trials

A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People

ProMuscle
Start date: November 2009
Phase: N/A
Study type: Interventional

The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.